[CYCC] QoQ Quarter Result on 31-Dec-2013 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
26-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- 28.88%
YoY- 25.29%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 735 356 396 299 309 264 212 128.89%
PBT -5,661 -5,635 -5,446 -4,026 -5,746 1,248 -3,356 41.65%
Tax -750 -816 -569 -452 -730 -230 -258 103.55%
NP -4,907 -4,812 -4,869 -3,559 -5,004 1,429 -3,082 36.31%
Tax Rate - - - - - 18.43% - -
Total Cost 5,642 5,168 5,265 3,858 5,313 -1,165 3,294 43.10%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin -667.62 -1,351.69 -1,229.55 -1,190.30 -1,619.42 541.29 -1,453.77 -40.44%
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
EPS -51.93 -51.14 -59.83 -44.87 -67.51 24.00 -75.55 -22.09%
EPS Diluted -51.93 -51.14 -59.83 -44.87 -67.51 24.00 -75.55 -22.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.